Trailblazing Stem Cell Research: New Hope for Schizophrenia Patients

person suffering from schizophrenia

A recent study led by Dr. Sergiu Pasca at Stanford University suggests that human induced pluripotent stem cells (iPSCs) could be used to identify potential new medications for schizophrenia. The research team developed a novel technique to produce astrocytes, star-shaped cells that support neurons, from iPSCs derived from patients with schizophrenia. Astrocytes play a critical […]

BioCardia Announces Issuance of Two Patents Related to Technology That Guides Interventional Therapies

BioCardia Logo

SUNNYVALE, Calif., April 04, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the issuance of two patent grants related to enabling technologies for delivery of its investigational autologous and allogeneic cell therapies. The United States Patent Office issued BioCardia Patent […]

Beyond Organ Transplants: The Power of Cell Transformation and Rejuvenation

Harnessing Stem Cell Biology for the Future of Medicine

The video discusses two major problems in modern medicine: the shortage of organs for transplantation and age-related diseases. Prof. Yossi Buganim’s lab focuses on transforming cells, such as converting skin cells into various other cell types, to create an unlimited source of cells for transplantation. This approach aims to address the organ shortage problem. Additionally, […]

Successful Growth of Functional Thymus Organoids from Human Stem Cells

illustration representing the thymus gland

The thymus, a crucial organ for adaptive immune response, produces T cells that attack invaders. With age and certain diseases, the thymus degrades, affecting immunity. Scientists from the University of Florida have grown functional thymus organoids from human stem cells for the first time, potentially aiding the development of patient-specific therapies for thymic dysfunction. Although […]

BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review Biologics License Application for NurOwn® for the Treatment of ALS

BrainStorm Logo

NEW YORK, March 27, 2023 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) will hold an Advisory Committee Meeting (‘ADCOM’) to discuss the company’s Biologics License Application (BLA) for NurOwn® for the treatment of amyotrophic lateral sclerosis (ALS). Given the […]

Genes that Form Specific Bones In the Womb Heal them Later in Life

NYU Langone Health

NEW YORK, March 20, 2023 /PRNewswire/ — Genes long known to control the formation of bones before birth also control bone healing later in life, a new study found.    Led by researchers at NYU Langone Health, a new study pinpointed key Hox genes, specific to each location in the body, as the controllers of stem cells […]

WWE Star Tommaso Ciampa Receives Final Stem Cell Treatment to Speed Up Recovery

Tommaso Ciampa stem cell treatment

WWE wrestler Tommaso Ciampa recently underwent his final stem cell treatment, as he continues to recover from multiple nagging injuries sustained during his in-ring career. Ciampa had been out of action since September and revealed on Instagram last week that he had traveled to Medellin, Colombia, to receive stem cell treatments from BioXcellerator, a leader […]

Positive Echocardiography Data from BioCardia Phase III CardiAMP Cell Therapy Heart Failure Trial Presented at American College of Cardiology Annual Meeting

BioCardia Logo

SUNNYVALE, Calif., March 06, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces that detailed echocardiography data from the roll-in cohort of the Phase III CardiAMP® Cell Therapy Heart Failure Trial is being presented today at the American College of Cardiology annual meeting by […]

Another Patient Cleared of HIV with Stem Cell Transplant

Illustration of HIV cells

A 53-year-old man in Germany, referred to as the ‘Düsseldorf patient’, has become the fifth person to be declared cleared of HIV after a bone marrow transplant that replaced his cells with HIV-resistant stem cells from a donor. The procedure was first used on Timothy Ray Brown, the ‘Berlin patient,’ in 2007, and later on […]